Shares of Gran Tierra Energy Inc. (NYSE:GTE) opened at $2.49, and ended 5.31% higher at $2.58. Nearly 1.47 million shares were traded by the close, lower than its average daily volume of 1.49 million shares.Gran Tierra Energy Inc. (GTE) Analyst Opinion
Gran Tierra Energy Inc. has a consensus outperform rating from 10 Wall Street analysts, and the number of shares currently sold short amount to at least 1.03% of shares outstanding. The stock sank -11.95% last month and is down -4.44 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover GTE having a buy-equivalent rating. Analysts have placed a $3.87 price target on Gran Tierra Energy Inc., suggesting a 50% gain from recent close. It’s currently trading about -14% below its 52-week high.
Gran Tierra Energy Inc. (GTE) failed to surprise the stock market in its last reported earnings when it earned $0.01 a piece versus the consensus-estimated $0.03. Its revenue totaled $110.03 million up 14.46% from the previous quarter.Gran Tierra Energy Inc. (NYSE:GTE) Intraday View
This stock (GTE) is ahead of its 52-week low with 33.68%. Its last month’s stock price volatility remained 6.04% which for the week stands at 4.52%. The share price has moved backward from its 20 days moving average, trading at a distance of -6.83% and stays -1.72% away from its 50 days moving average. Over the last five days, shares have faced -3.01% losses and now is up 10.7% since hitting its 200-day moving average of $2.33. Gran Tierra Energy Inc. (GTE) has made its way to a 12-month decline of -2.64%.
Turning to Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), its shares were trading at $76.93 a gain of $3.82, on the trading floor. The stock, after opening at $73.53, touched a high of $77.96 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.8. Agios Pharmaceuticals, Inc. has 3 buy ratings, 1 holds and 0 sells even after the stock tumbled -7.27% from its high of $82.96 to a $3.81 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 1.8 to 1.8 during a month. Analysts set a 12-month price target of $78.89 a share. The target implies a 2.55% spike from where the shares are currently trading. Also, the current price highlights a discount of 18.29% to analysts’ high consensus price target.Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Intraday Trading
The counter witnessed a trading volume of 0.51 million shares versus an average volume of 0.56 million shares during last trading session. Its last month’s stock price volatility remained 7.84% which for the week approaches 6.55%. The lowest price the stock reached in the last trading day was $72.79 and compares with the $45.11 52-week low. The stock recovered 70.54% since its low point and has performed 34.56% year-to-date.